Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 34374 | 112 | 35.3 | 34% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 1 | 4 | ECONOMICS//EDUCATION & EDUCATIONAL RESEARCH//PSYCHOL | 3876184 |
| 677 | 3 | DNA BARCODING//SPECIES IDENTIFICATION//GMO | 9162 |
| 3777 | 2 | FOOD AND DRUG LAW JOURNAL//BROMATOL 2//REQUIMTE SCI CHEM | 981 |
| 34374 | 1 | ADENO ASSOICATED VIRUS//BIOETHLAW//BIOSAFETY ADVISORY COUNCIL | 112 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | ADENO ASSOICATED VIRUS | authKW | 272639 | 1% | 100% | 1 |
| 2 | BIOETHLAW | address | 272639 | 1% | 100% | 1 |
| 3 | BIOSAFETY ADVISORY COUNCIL | address | 272639 | 1% | 100% | 1 |
| 4 | CFSB | address | 272639 | 1% | 100% | 1 |
| 5 | CRIME AND REHABILITATION DEBATES | authKW | 272639 | 1% | 100% | 1 |
| 6 | DISCLOSURE ISSUES | authKW | 272639 | 1% | 100% | 1 |
| 7 | DYSTROPHIN PLASMID | authKW | 272639 | 1% | 100% | 1 |
| 8 | EFBS | address | 272639 | 1% | 100% | 1 |
| 9 | EXCEPTIONAL OVERSIGHT | authKW | 272639 | 1% | 100% | 1 |
| 10 | GB PHARMA BIOTECHNOL | address | 272639 | 1% | 100% | 1 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Medical Ethics | 1509 | 7% | 0% | 8 |
| 2 | Law | 1334 | 21% | 0% | 23 |
| 3 | Ethics | 1142 | 11% | 0% | 12 |
| 4 | Social Sciences, Biomedical | 1126 | 13% | 0% | 15 |
| 5 | Social Issues | 208 | 4% | 0% | 5 |
| 6 | Health Care Sciences & Services | 143 | 8% | 0% | 9 |
| 7 | Biotechnology & Applied Microbiology | 108 | 14% | 0% | 16 |
| 8 | Genetics & Heredity | 97 | 13% | 0% | 15 |
| 9 | Medicine, Research & Experimental | 91 | 12% | 0% | 13 |
| 10 | Nutrition & Dietetics | 70 | 7% | 0% | 8 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | BIOETHLAW | 272639 | 1% | 100% | 1 |
| 2 | BIOSAFETY ADVISORY COUNCIL | 272639 | 1% | 100% | 1 |
| 3 | CFSB | 272639 | 1% | 100% | 1 |
| 4 | EFBS | 272639 | 1% | 100% | 1 |
| 5 | GB PHARMA BIOTECHNOL | 272639 | 1% | 100% | 1 |
| 6 | PROGRAMME SCI ETH SCI POLIT | 272639 | 1% | 100% | 1 |
| 7 | QIPP RIGHT CARE PROGRAM | 272639 | 1% | 100% | 1 |
| 8 | SERV BIOSAFETY BIOTECHNOL | 272639 | 1% | 100% | 1 |
| 9 | SWISS EXPERT COMM BIOSAFETY | 272639 | 1% | 100% | 1 |
| 10 | TTN | 136319 | 1% | 50% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | FOOD AND DRUG LAW JOURNAL | 17574 | 7% | 1% | 8 |
| 2 | TRANSFUSION SCIENCE | 4415 | 3% | 1% | 3 |
| 3 | HASTINGS CENTER REPORT | 4084 | 4% | 0% | 5 |
| 4 | HUMAN GENE THERAPY | 4001 | 6% | 0% | 7 |
| 5 | NATURE & RESOURCES | 2780 | 1% | 1% | 1 |
| 6 | JOURNAL OF FAMILY LAW | 2289 | 1% | 1% | 1 |
| 7 | AMERICAN BAR FOUNDATION RESEARCH JOURNAL | 2048 | 1% | 1% | 1 |
| 8 | CURRENT OPINION IN BIOTECHNOLOGY | 1879 | 4% | 0% | 4 |
| 9 | BIOTECHNOLOGY LAW REPORT | 1865 | 1% | 1% | 1 |
| 10 | ALTERNATIVES-SOCIAL TRANSFORMATION AND HUMANE GOVERNANCE | 1840 | 1% | 1% | 1 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | LEAVITT, WJ , (2001) REGULATING HUMAN GENE THERAPY: LEGISLATIVE OVERREACTION TO HUMAN SUBJECT PROTECTION FAILURES.ADMINISTRATIVE LAW REVIEW. VOL. 53. ISSUE 1. P. 315-341 | 4 | 100% | 1 |
| 2 | SATO, H , AKABAYASHI, A , KAI, I , (2006) APPRAISAL OF THE POLICYMAKING PROCESS IN JAPAN FOR GENE THERAPY: RESULTS OF NATIONAL SURVEYS OF ACADEMIC SOCIETIES, HOSPITALS, AND MEDICAL SCHOOLS.MEDICAL SCIENCE MONITOR. VOL. 12. ISSUE 9. P. PH7-PH15 | 10 | 31% | 0 |
| 3 | LISKER, R , CARNEVALE, A , VERA, PP , BETANCOURT, M , (2002) OPINIONS OF A GROUP OF UNIVERSITY STUDENTS ON SCIENCE AND TECHNOLOGY.REVISTA DE INVESTIGACION CLINICA. VOL. 54. ISSUE 5. P. 422-429 | 3 | 100% | 0 |
| 4 | COHEN-HAGUENAUER, O , ROSENTHAL, F , GANSBACHER, B , BOLHUIS, R , DORSCH-HASLER, KD , ESHHAR, Z , GAHRTON, G , HOKLAND, P , MELANI, C , RANKIN, E , ET AL (2002) OPINION PAPER ON THE CURRENT STATUS OF THE REGULATION OF GENE THERAPY IN EUROPE.HUMAN GENE THERAPY. VOL. 13. ISSUE 17. P. 2085-2110 | 5 | 56% | 4 |
| 5 | SATO, H , AKABAYASHI, A , KAI, I , (2006) PUBLIC, EXPERTS, AND ACCEPTANCE OF ADVANCED MEDICAL TECHNOLOGIES: THE CASE OF ORGAN TRANSPLANT AND GENE THERAPY IN JAPAN.HEALTH CARE ANALYSIS. VOL. 14. ISSUE 4. P. 203-214 | 6 | 35% | 0 |
| 6 | WOLF, SM , GUPTA, R , KOHLHEPP, P , (2009) GENE THERAPY OVERSIGHT: LESSONS FOR NANOBIOTECHNOLOGY.JOURNAL OF LAW MEDICINE & ETHICS. VOL. 37. ISSUE 4. P. 659-684 | 8 | 23% | 9 |
| 7 | GEE, AP , (2002) REGULATORY ISSUES IN CELLULAR THERAPIES.JOURNAL OF CELLULAR BIOCHEMISTRY. VOL. . ISSUE . P. 104 -112 | 2 | 100% | 0 |
| 8 | FITZGERALD, J , (1998) GENETICIZING DISABILITY: THE HUMAN GENOME PROJECT AND THE COMMODIFICATION OF SELF.ISSUES IN LAW & MEDICINE. VOL. 14. ISSUE 2. P. 147-163 | 3 | 75% | 5 |
| 9 | COHENHAGUENAUER, O , (1997) GENE THERAPY: REGULATORY ISSUES AND INTERNATIONAL APPROACHES TO REGULATION.CURRENT OPINION IN BIOTECHNOLOGY. VOL. 8. ISSUE 3. P. 361-369 | 3 | 75% | 7 |
| 10 | COHEN-HAGUENAUER, O , (1999) REGULATION OF GENE THERAPY.M S-MEDECINE SCIENCES. VOL. 15. ISSUE 5. P. 682 -690 | 4 | 50% | 0 |
Classes with closest relation at Level 1 |